Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03967535 · ClinicalTrials.gov registry record
Connectomics in Psychiatric Classification
A clinical trial of Dementia and Frontotemporal Dementia, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT03967535: Completed study of Dementia and Frontotemporal Dementia, sponsored by Washington University School of Medicine.
NCT03967535 is a study of Dementia and Frontotemporal Dementia that has completed, run by Washington University School of Medicine. The registered enrollment target is 30 participants, below the 7,723-participant average among 199 other Dementia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03967535, a study of Dementia and Frontotemporal Dementia, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Washington University Early Recognition Center is conducting a research study to examine brain functional connectivity and network patterns in participants with dementia.
Primary Outcome
The current project aims to uncover latent, homogenous, connectivity phenotypes using neuroimaging tools, which are free from the limitations of traditional diagnostic boundaries, and which correlate with clinical characteristics. The investigator will use resting state functional connectivity MRI (rs-fcMRI), diffusion MRI (dMRI) and tract-based spatial statistics (TBSS) to identify brain signatures that cut across psychiatric disorders.
Conditions Studied
Interventions
- DEVICE MRI Brain Imaging
- BEHAVIORAL Mental Health Assessment and Computerized Cognitive Test
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-12-01 |
| Est. Completion | 2019-09-05 |
What the finished NCT03967535 record still lists
NCT03967535 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 7,723-participant average among 199 other Dementia trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Dementia appearing as the primary indexed condition, and to 2 interventions - of which MRI Brain Imaging is the first listed.
NCT03967535 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT03967535 about?
NCT03967535 is a clinical study titled "Connectomics in Psychiatric Classification". Washington University Early Recognition Center is conducting a research study to examine brain functional connectivity and network patterns in participants with dementia.
What is the current status of trial NCT03967535?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2018-12-01. Estimated completion is 2019-09-05.
What conditions does trial NCT03967535 study?
This clinical trial studies the following conditions: Dementia, Frontotemporal Dementia, Dementia Alzheimers, Pick's Disease With Dementia.
What interventions are being tested in trial NCT03967535?
The interventions under investigation include: MRI Brain Imaging (DEVICE), Mental Health Assessment and Computerized Cognitive Test (BEHAVIORAL).
Who is sponsoring clinical trial NCT03967535?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03967535 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03967535's enrollment target sits among peer trials
30 170th of 199 higher than 27 of 199 other Dementia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
RECRUITING
-
Ferritin and Iron Burden in SAH sIRB
RECRUITING · Phase 1
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)
RECRUITING · Phase 1
-
Caregiver as Navigator: Develop Skills Online (CAN-DO)
RECRUITING · NA
-
Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older Adults
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI